Dubai:The 17th edition of the Excellence in Oncology Care (EIOC 2026) has officially begun at the InterContinental Dubai Festival City. The event has attracted over 3,500 participants, including leading oncology experts, healthcare professionals, and representatives from major healthcare institutions and industry organizations.
According to Emirates News Agency, the three-day congress, themed 'A New Era of Oncology Care,' is a multidisciplinary platform for scientific exchange and professional collaboration. It aims to explore the latest developments in cancer care, featuring participation from more than 56 countries, over 200 distinguished speakers, and 30 industry partners.
Ambassador Professor Abdulsalam AlMadani, Chairman of INDEX Holding, emphasized the importance of this gathering, noting that breakthroughs in cancer research have the potential to significantly impact patient care. He highlighted Dubai's role in facilitating global medical expertise to advance oncology missions.
Dr. Shaheenah Dawood, President of the EIOC Conference, remarked that the congress serves as a vital platform for exchanging knowledge and exploring new possibilities in cancer care. The event focuses on multidisciplinary collaboration and scientific innovation to improve patient outcomes.
The scientific program includes over 13 sessions across various oncology disciplines, addressing emerging treatment approaches and advances in cancer research. The congress also features more than 60 scientific poster presentations and offers 61 Continuing Medical Education (CME) credit hours accredited by the Dubai Health Authority.
Organized by INDEX Conferences and Exhibitions, EIOC 2026 receives support from key industry sponsors such as Bayer, Lilly, MSD, and Novartis, along with several distinguished institutions and professional organizations. The event underscores Dubai's growing role as a destination for specialized medical knowledge and international scientific collaboration.